Chronic Lymphocytic Leukemia Clinical Trials in Milan, MI
2 recruitingMilan, MI, Italy
Showing 1–2 of 2 trials
Recruiting
Phase 2
Venetoclax, Rituximab and Ibrutinib in TN Patients With CLL Undetectable Minimal Residual Disease (uMRD) in Treatment-naïve Patients With Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia (CLL)
Paolo Ghia55 enrolled1 locationNCT04758975
Recruiting
Phase 2
Fixed-duration Therapy With Ibrutinib and Obinutuzumab (GA-101) in Treatment-naïve Patients With CLL
Chronic Lymphocytic Leukemia
Paolo Ghia53 enrolled1 locationNCT04908228